Two Blastic Plasmacytoid Dendritic Cell Neoplasms treated with the CD123‐targeted agent Tagraxofusp presenting divergent outcomes
Year: 2026
Type: article
Abstract: Dear Editors
DOI: 10.1111/ddg.70608
Institution: RWTH Aachen University
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,480
OpenAlex ID: W7212632750
